Search

Search Constraints

You searched for: Author/Creator Nowicka, Grażyna

Search Results

41. Scientific and technical guidance for the preparation and presentation of a health claim application (Revision 2). (31st January 2017)

42. Scientific and technical guidance for the preparation and presentation of an application for authorisation of an infant and/or follow‐on formula manufactured from protein hydrolysates. (11th May 2017)

43. Scientific Opinion on taxifolin‐rich extract from Dahurian Larch (Larix gmelinii). (14th February 2017)

44. Scientific Opinion on the energy conversion factor of d‐tagatose for labelling purposes. (16th November 2016)

45. Scientific Opinion on the safety and suitability for use by infants of follow‐on formulae with a protein content of at least 1.6 g/100 kcal. (11th May 2017)

46. Scientific Opinion related to a notification from DuPont Nutrition Biosciences Aps on behenic acid from mustard seeds to be used in the manufacturing of certain emulsifiers pursuant to Article 21(2) of Regulation (EU) No 1169/2011 – for permanent exemption from labelling. (15th November 2016)

47. Stablor® and reduction of visceral fat while maintaining lean mass: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006. (28th February 2017)

48. Statement on the safety of EstroG‐100™ as a novel food pursuant to Regulation (EC) No 258/97. (8th May 2017)

49. Statement on the safety of synthetic l‐ergothioneine as a novel food – supplementary dietary exposure and safety assessment for infants and young children, pregnant and breastfeeding women. (13th November 2017)

50. Statement on the safety of taxifolin‐rich extract from Dahurian Larch (Larix gmelinii). (13th November 2017)